Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Jan 31;134(2):303-313.
doi: 10.1042/CS20190913.

Double-stranded RNA and Toll-like receptor activation: a novel mechanism for blood pressure regulation

Affiliations
Review

Double-stranded RNA and Toll-like receptor activation: a novel mechanism for blood pressure regulation

Vanessa Dela Justina et al. Clin Sci (Lond). .

Abstract

Toll-like receptors (TLRs), such as TLR4 and 9, recognize pathogen-associated molecular pattern (PAMPs) and danger-associated molecular patterns (DAMPs) and are associated with increased blood pressure (BP). TLR3, residing in the endosomal compartment, is activated by viral double-stranded RNA (dsRNA) leading to activation of TIR receptor domain-containing adaptor inducing IFN-β (TRIF) dependent pathway. Besides foreign pathogens, the immune system responds to endogenous markers of cellular damage such as mitochondrial dsRNA (mtdsRNA). New evidence has shown a link between dsRNA and increased BP. Moreover, TLR3 activation during pregnancy was demonstrated to develop preeclampsia-like symptoms in both rats and mice. Hence, we hypothesize that the dsRNA derived from viral nucleic acids or cellular damage (mtdsRNA) will increase the inflammatory state through activation of TLR3, contributing to vascular dysfunction and increased BP. Therefore, inhibition of TLR3 could be a therapeutic target for the treatment of hypertension with potential improvement in vascular reactivity and consequently, a decrease in BP.

Keywords: TLR3; hypertension; mitochondrial dsRNA.

PubMed Disclaimer

Conflict of interest statement

Competing Interests

The authors declare that there are no competing interests associated with the manuscript.

Figures

Figure 1.
Figure 1.. dsRNA–TLR3 signaling cascade
dsRNA is internalized by cell surface receptors via endocytosis and then recognized by TLR3 present in the endosome leading to subsequent signaling via the adaptor protein TRIF. Further, dsRNA can also be recognized by cytoplasmic RNA helicase RIG-I (retinoic acid-inducible gene I) and melanoma differentiation-associated gene-5 (MDA5) into the cytoplasm through SID transporter. Abbreviations: dsRNA, double-stranded RNA; TLR3, toll-like receptor 3; RIG-I, a retinoic acid-inducible gene I; MDA5, melanoma differentiation-associated gene. Adapted from Nguyen et al. [45] (permission obtained under license number 4757830360815).
Figure 2.
Figure 2.. The schematic hypothesis of the proposed mechanisms of TLR3-inhibition to prevent hypertension
dsRNA derived from viral nucleic acids or cellular damage trigs TLR3 leading to the production of inflammatory cytokines and IFN, contributing to vascular dysfunction and increased blood pressure. Inhibition of TLR3 could potentially improve vascular reactivity and consequently, decreases blood pressure. Abbreviations: dsRNA, double-stranded RNA; IFN, interferon; mtdsRNA, mitochondrial dsRNA; TLR3, toll-like receptor 3. Key references: [13,61,91].

References

    1. Malta DC, Gonçalves RPF, Machado ÍE, Freitas MI, de F, Azeredo C et al. (2018) Prevalência da hipertensão arterial segundo diferentes critérios diagnósticos, Pesquisa Nacional de Saúde. Rev. Bras. Epidemiol 21, 1–15, 10.1590/1980-549720180021.supl.1 - DOI - PubMed
    1. Harrison DG (2014) The immune system in hypertension early studies in immunity and hypertension. Trans. Am. Clin. Climatol Assoc 125, 130–140 - PMC - PubMed
    1. Singh MV, Chapleau MW, Harwani SC and Abboud FM (2014) The immune system and hypertension. Immunol. Res 59, 243–253, 10.1007/s12026-014-8548-6 - DOI - PMC - PubMed
    1. Gao W, Xiong Y, Li Q and Yang H (2017) Inhibition of toll-like receptor signaling as a promising therapy for inflammatory diseases: A journey from molecular to nano therapeutics. Front. Physiol 8, 1–20, 10.3389/fphys.2017.00508 - DOI - PMC - PubMed
    1. Bomfim GF, Luciano F and Carneiro FS (2017) Are the innate and adaptive immune systems setting hypertension on fire? Pharmacol. Res 117, 377–393, 10.1016/j.phrs.2017.01.010 - DOI - PubMed

Publication types